SMRT co-repressors, transcriptional co-repressors that...

Details SMRT co-repressors, transcriptional co-repressors that... SMRT co-repressors, transcriptional co-repressors that...

2008-01-01

2008-01-01

Qian, Celine (Department: 1636)

Chemistry: molecular biology and microbiology

Micro-organism, per se ; compositions thereof; proces of...

Fungi

C435S325000, C435S320100, C536S023400, C536S023500, C536S023100

Reexamination Certificate

active

07314747

ABSTRACT:
The present invention relates to isolated polynucleotides encoding a family of silencing mediators of retinoic acid and thyroid hormone receptor (SMRT) isoforms, including vertebrate and invertebrate isoforms thereof. The invention also relates to polypeptide SMRT co-repressors encoded by invention SMRT polynucleotides, and to peptide portions thereof that can modulate transcriptional potential of a nuclear receptor. In addition, the invention relates to chimeric molecules and to complexes containing a SMRT co-repressor or peptide portion thereof, to antibodies that specifically bind such compositions, and to methods for identifying an agent that modulates the repressor potential of a SMRT co-repressor. The invention also provides methods for identifying an agent that modulates a function of a SMRT co-repressor; for modulating the transcriptional potential of a nuclear receptor in a cell using the compositions of the invention; and for identifying a molecule that interacts specifically with a SMRT co-repressor.

REFERENCES:
patent: 4981784 (1991-01-01), Evans et al.
patent: 5071773 (1991-12-01), Evans et al.
patent: 5091518 (1992-02-01), Sucov et al.
patent: 5260432 (1993-11-01), Takaku et al.
patent: 6248559 (2001-06-01), Takashima et al.
Chen, et al. Nature, Oct. 1995, vol. 377, No. 6548, pp. 454-457.
Ordentlich, et al. PNAS USA, vol. 96, No. 6, pp. 2639-2644.
Park, et al. PNAS USA, vol. 96, No. 7, pp. 3519-3524.
GenBank Accession No. NM—002900.1, GI: 4506452, Mar. 19, 1999.
GenBank Accession No. O75376, GI: 47117817, Feb. 7, 2006.
http://algoart.com/aatable.htm, printed on Feb. 28, 2007.
Ordentlich, et al. PNAS USA, vol. 96, No. 6, pp. 2639-2644, Mar. 1999.
Park, et al. PNAS USA, vol. 96, No. 7, pp. 3519-3524, Mar. 1999.
Ayer et al., “Mad-Max Transcriptional Repression is Mediated by Ternary Complex Formation with Mammalian Homologs of Yeast Repressor Sin3”Cell80:767-776 (1995).
Bahouth et al. “Immunological Approaches for Probing Receptor Structure and Function”TIPS Reviews12:338-343 (1991).
Baniahmad et al., “Modular Srurcture of a Chicken Lysozyme Silencer: Involvement of an Unusual Thyroid Hormone Receptor Binging Site”Cell61:505-514 (1990).
Baniahmad et al., “Kindred S Thyroid Hormone Receptor is an Active and Constitutive Silencer and a Repressor for Thyroid Hormone and Retinoic Acid Responses”Proc. Natl. Acad. Sci. USA89:10633-10637 (1992).
Baniahmad et al., “A Transferable Silencing Domain is Present in the Thyroid Hormone Receptor, in the v-erbA Oncogene Product and in the Retinoic Acid Receptor”EMBO J.11(3) :1015-1023 (1992).
Baniahmad et al., “Interaction of Human Thyroid Hormone Receptor β with Transcription Factor TFIIB May Mediate Target Gene Derepression and Activation by Thryoid Hormone”Proc. Natl. Acad. Sci. USA90:8832-8836 (1993).
Baniahmad et al., “The τ4 Activation Domain of the Thyroid Hormone Receptor is Required for Release of a Putative Corepressor(s) Necessary for Transcriptional Silencing”Mol. Cell. Biol.15 (1):76-86 (1995).
Barlow et al., “Thyroid Abnormalities and Hepatocellular Carcinoma in Mice Transgenic for v-erbA” EMBO J.13:4241-4250 (1994).
Berger et al., “Interaction of Glucocorticoid Analogues with the Human Glucocorticoid Receptor”J. Steroid Biochem. Molec. Biol.41(3-8) : 733-738 (1992).
Bourguet et al., “Crystal Structure of the Ligand-Binding Domain of the Human Nuclear Receptor RXR-α”Nature375:377-382 (1995).
Brent et al., “Thyroid Hormone Aporeceptor Represses T3-Inducible Promoters and Blocks Activity of the Retinoic Acid Receptor”New Biol.1(3) :329-336 (1989).
Bugge et al., “RXRα, a Promiscuous Partner of Retinoic Acid and Thyroid Hormone Receptors”EMBO J.11(4) :1409-1418 (1992).
Casanova et al., “Functional Evidence for Ligand-Dependent Dissociation of Thyroid Hormone and Retinoic Acid Receptors from an Inhibitory Cellular Factor”Mol. Cell. Biol.14(9) :5756-5765 (1994).
Cavaillès et al., “Interaction of Proteins with Transcriptionally Active Estrogen Receptors”Proc. Natl. Acad. Sci. USA91:10009-10013 (1994).
Damm et al., “Protein Encoded by v-erbAFunctions as a Thyroid-Hormone Receptor Antagonist”Nature339 (6226) :593-597 (1989).
Damm et al., “Functional Inhibition of Retinoic Acid Response by Dominant Negative Retinoic Acid Receptor Mutants”Proc. Natl. Acad. Sci. USA90:2989-2993 (1993).
Damm and Evans, “Identification of a Domain Required for Oncogenic Activity and Transcriptional Suppression by v-erbA and Thyroid-Hormone Receptor α”Proc. Natl. Acad. Sci. USA90:10668-10672 (1993).
Durfee et al. “The Retinoblastoma Protein Associates with the Protein Phosphatase Type 1 Catalytic Subunit”Genes&Dev.7:555-569 (1993).
Fondell et al., “Unliganded Thyroid Hormone Receptor Inhibits Formation of a Functional Preinitiation Complex: Implications for Active Repression”Genes&Dev.7:1400-1410 (1993).
Gandrillon et al., “Expression of the v-erbAOncogene in Chicken Embryo Fibroblasts Stimulates Their Proliferation In Vitro and Enhances Tumor Growth In Vivo”Cell49:687-697 (1987).
Halachmi et al., “Estrogen Receptor-Associated Proteins: Possible Mediators of Hormone-Induced Transcription”Science264:1455-1458 (1994).
Hollenberg and Evans, “Multiple and Cooperative Trans-Activation Domains of the Human Glucocorticoid Receptor”Cell55:899-906 (1988).
Kliewer et al., “Retinoid X Receptor Interacts with Nuclear Receptors in Retinoic Acid, Thyroid Hormone and Vitamin D3Signalling”Nature355:446-449 (1992).
Le Douarin et al., “The N-terminal Part of TIF1, a Putative Mediator of the Ligand-Dependant Activation Function (AF-2) of Nuclear Receptors, is Fused to B-raf in the Oncogenic Protein T18”EMBO J.14(9) :2020-2033 (1995).
Lee et al., “Interaction of the Thyroid-Hormone Receptor with a Conserved Transcriptional Mediator”Nature374:91-94 (1995).
Levine and Manley, “Transcriptional Repression of Eukaryotic Promoters”Cell59:405-408 (1989).
Mangelsdorf et al., “Nuclear Receptor that Identifies a Novel Retinoic Acid Response Pathway”Nature345 (6272) :224-229 (1990).
Mangelsdorf et al., “A Direct Repeat in the Cellular Retinol-Binding Protein Type II Gene Confers Differential Regulation by RXR and RAR”Cell66:555-561 (1991).
Muñoz et al. “Characterization of the Hormone-binding Domain of the Chicken c-erbA/Thyroid Hormone Receptor Protein”EMBO J.7:155-159 (1988).
Saitou et al., “Inhibition of Skin Development by Targeted Expression of a Dominant-Negative Retinoic Acid Receptor”Nature374:159-162 (1995).
Sap et al., “Thec-erb-AProtein is a High-Affinity Receptor for Thyroid Hormone”Nature324:635-640 (1986).
Sap et al., “Repression of Transcription Mediated at a Thyroid Hormone Response Element by the v-erb-AOncogene Product”Nature340:242-244 (1989).
Schreiber-Agus et al., “An Amino-Terminal Domain of Mxil Mediates Anti-Myc Oncogenic Activity and Interacts with a Homolog of the Yeast Transcriptional Repressor SIN3”Cell80:777-786 (1995).
Seol et al., “Isolation of Proteins That Interact Specifically with the Retinoid X Receptor: Two Novel Orphan Receptors”Molecular Endocrinology9(1):72-85 (1995).
Thompson et al., “Identification of a Novel Thyroid Hormone Receptor Expressed in the Mammalian Central Nervous System”Science237 :1610-1614 (1987).
Tsai et al., “A Mutated Retinoic Acid Receptor-α Exhibiting Dominant-Negative Activity Alters the Lineage Development of a Multipotent Hematopoietic Cell Line”Genes&Dev.6:2258-2269 (1992).
Tsai and Collins, “A Dominant Negative Retinoic Acid Receptor Blocks Neutrophil Differentiation at the Promyelocyte Stage”Proc. Natl. Acad. Sci. USA90:7153-7157 (1993).

Affiliated with

Also associated with

Rating

SMRT co-repressors, transcriptional co-repressors that... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with SMRT co-repressors, transcriptional co-repressors that..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and SMRT co-repressors, transcriptional co-repressors that... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2797808